Abbott Completes Quarter-Billion-Dollar Purchase of OptiMedica

While Abbott Laboratories still faces lagging sales in its medical device segment, the company has closed a quarter-billion-dollar purchase to gain entry into the laser-assisted cataract surgery market.
Qmed